UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device

Annals of allergy, asthma, & immunology, 2010-08, Vol.105 (2), p.168-173

2010

Volltextzugriff (PDF)

Etanercept as Monotherapy in Patients with Psoriasis

The New England journal of medicine, 2003-11, Vol.349 (21), p.2014-2022

2003

Volltextzugriff (PDF)

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

Clinical and experimental allergy, 2002-07, Vol.32 (7), p.1020-1028

2002

Volltextzugriff (PDF)

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

Allergy (Copenhagen), 2003-12, Vol.58 (12), p.1268-1276

2003

Volltextzugriff (PDF)

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

Journal of allergy and clinical immunology, 1996-03, Vol.97 (3), p.749-755

1996

Volltextzugriff (PDF)

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06

Journal of allergy and clinical immunology, 1995, Vol.95 (5), p.1128-1132

1995

Volltextzugriff (PDF)

Mometasone Furoate Nasal Spray is Safe and Effective for One-Year Treatment of Children With Perennial Allergic Rhinitis

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S52-S53

2008

Volltextzugriff (PDF)

Pharmacokinetic Evaluation of BDP HFA Nasal Aerosol and BDP HFA Inhalation Aerosol in Healthy Subjects

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB256-AB256

2011

Volltextzugriff (PDF)

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis

Annals of allergy, asthma, & immunology, 2005-12, Vol.95 (6), p.600-606

2005

Volltextzugriff (PDF)

BDP HFA Nasal Aerosol Effectively Improves Nasal Symptom Relief and Health-Related Quality of Life (QOL) in Subjects with Seasonal Allergic Rhinitis (SAR)

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB200-AB200

2011

Volltextzugriff (PDF)

Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis

Journal of allergy and clinical immunology, 1996-08, Vol.98 (2), p.302-308

1996

Volltextzugriff (PDF)

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

Annals of allergy, asthma, & immunology, 2003-05, Vol.90 (5), p.536-542

2003

Volltextzugriff (PDF)

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar

Annals of allergy, asthma, & immunology, 2005-11, Vol.95 (5), p.474-479

2005

Volltextzugriff (PDF)

Pharmacokinetic Model of Epinastine, an H1 Antagonist, after Nasal Administration

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S50-S50

2008

Volltextzugriff (PDF)

Use of Intranasal Cromolyn Sodium for Allergic Rhinitis

Mayo Clinic proceedings, 2002-04, Vol.77 (4), p.350-354

2002

Volltextzugriff (PDF)

Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension

Journal of human hypertension, 1997-04, Vol.11 (4), p.239-244

1997

Volltextzugriff (PDF)

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

Clinical and experimental allergy, 2009-10, Vol.39 (10), p.1622-1622

2009

Volltextzugriff (PDF)

A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis

The Journal of family practice, 1998-08, Vol.47 (2), p.118-125

1998

Volltextzugriff (PDF)

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis

Journal of allergy and clinical immunology, 2000-06, Vol.105 (6), p.1101-1107

2000

Volltextzugriff (PDF)

A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis

Journal of allergy and clinical immunology, 1999-07, Vol.104 (1), p.107-114

1999

Volltextzugriff (PDF)

Efficacy and Safety of Ciclesonide Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

Journal of allergy and clinical immunology, 2006-02, Vol.117 (2), p.S168-S168

2006

Volltextzugriff (PDF)

Intranasal corticosteroids in the treatment of allergic rhinitis

Allergy and asthma proceedings, 2007-05, Vol.28 Suppl 1 (3), p.S25-32

2007

Volltextzugriff (PDF)

Research abstracts presented at the Western Society of Allergy, Asthma, and Immunology Meeting, January 25‐29, 2009

Allergy and asthma proceedings, 2009-03, Vol.30 (2), p.210-210

2009

Volltextzugriff (PDF)

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis

Journal of allergy and clinical immunology, 1994-11, Vol.94 (5), p.818-825

1994

Volltextzugriff (PDF)

Improved quality of life (QoL) among seasonal allergic rhinitis (SAR) patients treated with olopatadine HCl nasal spray, 0.4% and olopatadine HCl nasal spray, 0.6% compared to vehicle

Journal of allergy and clinical immunology, 2004-02, Vol.113 (2), p.S25-S25

2004

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(37)
Humans
(33)
Biological And Medical Sciences
(23)
Female
(23)
Male
(23)
Medical Sciences
(22)
Allergy
(20)
Adult
(19)
Rhinitis, Allergic, Seasonal - Drug Therapy
(18)
Double-Blind Method
(17)
Immunology
(16)
Adolescent
(15)
Aged
(15)
Middle Aged
(15)
Pharmacology. Drug Treatments
(15)
Administration, Intranasal
(13)
Child
(13)
Physical Sciences
(13)
Fluticasone
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device

Etanercept as Monotherapy in Patients with Psoriasis

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06

Mometasone Furoate Nasal Spray is Safe and Effective for One-Year Treatment of Children With Perennial Allergic Rhinitis

Pharmacokinetic Evaluation of BDP HFA Nasal Aerosol and BDP HFA Inhalation Aerosol in Healthy Subjects

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis

BDP HFA Nasal Aerosol Effectively Improves Nasal Symptom Relief and Health-Related Quality of Life (QOL) in Subjects with Seasonal Allergic Rhinitis (SAR)

Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar

Pharmacokinetic Model of Epinastine, an H1 Antagonist, after Nasal Administration

Use of Intranasal Cromolyn Sodium for Allergic Rhinitis

Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis

A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis

Efficacy and Safety of Ciclesonide Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

Intranasal corticosteroids in the treatment of allergic rhinitis

Research abstracts presented at the Western Society of Allergy, Asthma, and Immunology Meeting, January 25‐29, 2009

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis

Improved quality of life (QoL) among seasonal allergic rhinitis (SAR) patients treated with olopatadine HCl nasal spray, 0.4% and olopatadine HCl nasal spray, 0.6% compared to vehicle

Suchergebnisse filtern